A recent FDA alert, along with new labeling, warns health professionals about the possibility of QT prolongation and Torsades de Pointes (TdP) in patients treated with the antipsychotic drug Haldol (haloperidol).
The risk appears to be higher wh...
Lawyer Central Also Recommends These Stories: